Clover Health Investments Corp ( (CLOV) ) has released its Q3 earnings. Here is a breakdown of the information Clover Health Investments Corp presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Clover Health Investments Corp. is a technology-driven healthcare company focused on providing Medicare Advantage plans, leveraging its proprietary Clover Assistant platform to enhance clinical decision-making and improve health outcomes.
In its third quarter of 2025, Clover Health reported a significant increase in both membership and revenue, achieving a 35% growth in Medicare Advantage membership and a 50% rise in total revenues year-over-year. Despite these gains, the company experienced a GAAP net loss of $24 million but managed to maintain a positive Adjusted EBITDA of $2 million.
Key financial highlights include a year-to-date Adjusted EBITDA of $45 million and an Adjusted Net Income of $44 million. The company also revised its full-year 2025 guidance, projecting increased insurance revenue and improved Adjusted SG&A metrics. Clover Health aims to maintain its growth trajectory into 2026, with expectations of enhanced profitability driven by favorable CMS rate updates and increased adoption of its Clover Assistant.
Looking ahead, Clover Health’s management remains optimistic about the company’s ability to sustain above-market growth and profitability. With strategic initiatives in place and a focus on expanding its technology platform, Clover Health is poised to continue improving its financial performance and delivering value to its members.